Reviews Supplements Allergan - Spire Ophthalmology May 2012 : Page 1

Ocular Allergy: A Scientific Review and Expert Case Debate Michael B. Raizman, MD (chair); Jodi I. Luchs, MD; Joseph P. Shovlin, OD; and Raoul L. Wolf, MD Release Date: May 3, 2012 Expiration Date: May 3, 2013 TARGET AUDIENCE t Allergists t Ophthalmologists ACTIVITY PURPOSE Educate physicians on the various forms of ocular allergies as well as current management options and emerging treatment. STATEMENT OF NEED Allergic conjunctivitis is one of the most common conditions seen by ophthalmologists, optometrists, and allergists. During the past 40 years, both the incidence and prevalence of allergic conjunctivitis have risen exponentially, and they continue to rise. Numerous treatment strategies abound without any clear consensus from various clinical studies, creating a challenge for healthcare providers. Current ocular allergy treatment options are effective only at mediating the symptoms, and these options have many different methods of action and modes of delivery. Allergists, ophthalmologists, and optometrists must become better versed in the classification, severity indices, and various options available for treatment of ocular allergy and they must also become cognizant of the differences between the various subtypes of dry eye disease and ocular allergy. In addition, they must be able to recognize the severity of dry eye disease and ocular allergy. LEARNING OBJECTIVES After completing this enduring activity, participants should be able to: t Differentiate between the various types of ocular allergies based on clinical presentation t Individualize management options for ocular allergy based on disease severity, patient factors, and associated risks and benefits t Describe the newer studies on the diagnosis and treatment of ocular allergy that are rapidly changing potential treatment algorithms DESIRED RESULT/OUTCOME: Ophthalmologists know and apply current treatment strategies through an individualized stepwise approach to optimize treatment outcomes in patients with ocular allergy. Part 2 of 2 Jointly sponsored by Dannemiller, Pennsylvania College of Optometry at Salus University, and Spire Learning Supported by an educational grant from Allergan, Inc. May 2012 1

Next Page

Publication List
Using a screen reader? Click Here